Παραπομπή σε μορφή APA (7η εκδ.)

KJ, S., Y, Z., SS, B., BB, Z., AC, R., AV, S., . . . ES, G. (2025). Oral octanoylcarnitine alleviates exercise intolerance in mouse models of long-chain fatty acid oxidation disorders. JCI insight, 10(22), . https://doi.org/10.1172/jci.insight.199443

Παραπομπή σε μορφή Chicago (17η εκδ.)

KJ, Solo, et al. "Oral Octanoylcarnitine Alleviates Exercise Intolerance in Mouse Models of Long-chain Fatty Acid Oxidation Disorders." JCI Insight 10, no. 22 (2025). https://doi.org/10.1172/jci.insight.199443.

Παραπομπή σε μορφή MLA (9th εκδ.)

KJ, Solo, et al. "Oral Octanoylcarnitine Alleviates Exercise Intolerance in Mouse Models of Long-chain Fatty Acid Oxidation Disorders." JCI Insight, vol. 10, no. 22, 2025, https://doi.org/10.1172/jci.insight.199443.